<DOC>
	<DOC>NCT00089557</DOC>
	<brief_summary>This study is an open-label, multicenter, extension study for subjects who completed NeurogesX Study C111 and received treatment with NGX-4010 (Capsaicin Patch) within 12 weeks (up to +7days) before entry into Study C114</brief_summary>
	<brief_title>An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>Key Eligibility Criteria: Must have completed NeurogesX Study C111 and received treatment with NGX4010 (Capsaicin Patch) within 12 weeks (up to +7 days) before entry into Study C114. Demonstrated adherence to protocol requirements during Study C111, and willing and able to comply with protocol requirements for the duration of the study participation. Must not have had any serious adverse experience since enrollment in Study C111, whether or not considered to be study drugrelated. Must have intact skin at the treatment area. Must be prepared to remain on the same pain medications at the same doses as before the study for the entire duration of the study (36 weeks). Must not use topical pain medications on painful areas. Must be at least 18 years old, not pregnant, and able to take care of self independently, with only occasional assistance if needed. No history or current problem with substance abuse.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2004</verification_date>
	<keyword>Dermal assessment</keyword>
	<keyword>Pain assessment</keyword>
	<keyword>Diary</keyword>
	<keyword>Analgesics</keyword>
	<keyword>Capsaicin</keyword>
	<keyword>Herpes zoster</keyword>
	<keyword>Neuralgia</keyword>
	<keyword>Pain</keyword>
	<keyword>HIV Infections</keyword>
	<keyword>Peripheral Nervous System Diseases</keyword>
	<keyword>Diabetic Neuropathies</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Polyneuropathies</keyword>
	<keyword>Complementary Therapies</keyword>
</DOC>